• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL PREPARED PLATED MEDIA: R2A AGAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL PREPARED PLATED MEDIA: R2A AGAR Back to Search Results
Catalog Number 299480
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/06/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was noticed during bioburden assay that bd bbl¿ prepared plated media: r2a agar had contamination in media.
 
Manufacturer Narrative
Investigation: during manufacturing of material 299480, media is formulated and sent through a high temperature short time sterilizer to remove bioburden.The petri dishes are subjected to uv radiation to decrease bioburden.The petri dishes are filled in a positive pressure hepa filtered environment.The filled plates are cooled and immediately wrapped into sleeves to decrease the introduction of microbes.Sleeves are then packaged into cartons and then transferred to a refrigerated truck (2 to 8 degrees c) for shipment to the distributor.Bd distributors are provided with the storage guidelines for the shipping and handling of bd media of 2 to 8 degrees c in a dark place.The batch history record for batch 0274522 was satisfactory at time of release and no quality notifications were generated during manufacturing and inspection.The release testing that is performed on this product does include bioburden testing.A sample of plates are incubated at 25 degrees c and at 35 degrees c for approximately 72 hours.All bioburden testing performed on this batch was satisfactory per bd internal procedures.Affected product does not have any sterility claims; the product is.Tested for bioburden prior to release to ensure that it conforms to product specifications.However, this does not ensure that the end-user will not receive a contaminated plate.The complaint history was reviewed, and no other complaints have been taken on batch 0274522.Retention samples from batch 0274522 were not available for inspection.One photo was received for investigation.The photo shows the bottom of a plate from batch 0274522 (time stamp 1302) with bacterial growth on the media.No return samples were received for investigation.This complaint has been confirmed.Bd will continue to trend complaints for contamination.Based on the low defect rate for this batch, no actions are planned at this time.
 
Event Description
It was noticed during bioburden assay that bd bbl¿ prepared plated media: r2a agar had contamination in media.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL PREPARED PLATED MEDIA: R2A AGAR
Type of Device
NA
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
MDR Report Key11244781
MDR Text Key230248484
Report Number1119779-2021-00160
Device Sequence Number1
Product Code JSG
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 08/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/26/2021
Device Catalogue Number299480
Device Lot Number0274522
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/08/2021
Initial Date FDA Received01/28/2021
Supplement Dates Manufacturer Received08/27/2021
Supplement Dates FDA Received09/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-